Latest Stock Split Details
Key information about CTI BioPharma Corp.'s most recent stock split
Split Date: 2017-01-03
Split Ratio: 1:10
Price Before Split: $0.39
Price After Split: $0.04
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 10.00 times fewer shares (a 1:10 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of CTI BioPharma Corp.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2017-01-03 | 1:10 | Yes | $0.39 | $0.04 |
| 2012-09-04 | 1:5 | Yes | $0.39 | $0.08 |
| 2011-05-16 | 1:6 | Yes | $0.27 | $0.04 |
| 2008-09-02 | 1:10 | Yes | $0.23 | $0.02 |
| 2007-04-16 | 1:4 | Yes | $1.49 | $0.37 |
About CTI BioPharma Corp.
Company overview and industry information
CTI BioPharma Corp. (CTIC) operates in the Biotechnology industry. The recent 1-for-10 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to CTI BioPharma Corp. Summary